Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroya Takeuchi

Showing results (411-420 of 483) with videos related to

Pageof 49
Sort By:
Global Health & Medicine|March 3, 2025
Postoperative adjuvant chemotherapy in patients with gastric cancer based on the Nationwide Gastric Cancer Registry in JapanYasuhide Yamada, Yasuyuki Seto, Takaki Yoshikawa, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 6, 2024
A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in JapanEisuke Booka, Hiroya Takeuchi, Hirotoshi Kikuchi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 29, 2020
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909Shuichi Hironaka, Azusa Komori, Ryunosuke Machida, et al.
Annals of Surgical Oncology|August 2, 2020
Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort StudySatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Cancer Medicine|April 25, 2023
Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinomaRyuta Muraki, Yoshifumi Morita, Shinya Ida, et al.
Annals of Gastroenterological Surgery|July 27, 2019
Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2017Hiroshi Hasegawa, Arata Takahashi, Yoshihiro Kakeji, et al.
Cancer Medicine|January 18, 2026
Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal CancerKeiso Ho, Satoru Matsuda, Eisuke Booka, et al.
Annals of Surgical Oncology|January 14, 2026
Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109Ryosuke Kita, Ken Kato, Ryunosuke Machida, et al.
Annals of Surgical Oncology|August 8, 2020
ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer PatientsSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Annals of Gastroenterological Surgery|January 16, 2023
Defining conversion therapy for esophageal squamous cell carcinomaSatoru Matsuda, Takahiro Tsushima, Ken Kato, et al.
Pageof 49

Showing results (411-420 of 483) with videos related to

Sort By:
Pageof 49
Global Health & Medicine|March 3, 2025
Postoperative adjuvant chemotherapy in patients with gastric cancer based on the Nationwide Gastric Cancer Registry in JapanYasuhide Yamada, Yasuyuki Seto, Takaki Yoshikawa, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 6, 2024
A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in JapanEisuke Booka, Hiroya Takeuchi, Hirotoshi Kikuchi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 29, 2020
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909Shuichi Hironaka, Azusa Komori, Ryunosuke Machida, et al.
Annals of Surgical Oncology|August 2, 2020
Validation Study of Fibrinogen and Albumin Score in Esophageal Cancer Patients Who Underwent Esophagectomy: Multicenter Prospective Cohort StudySatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Cancer Medicine|April 25, 2023
Phosphatidylcholine in bile-derived small extracellular vesicles as a novel biomarker of cholangiocarcinomaRyuta Muraki, Yoshifumi Morita, Shinya Ida, et al.
Annals of Gastroenterological Surgery|July 27, 2019
Surgical outcomes of gastroenterological surgery in Japan: Report of the National Clinical Database 2011-2017Hiroshi Hasegawa, Arata Takahashi, Yoshihiro Kakeji, et al.
Cancer Medicine|January 18, 2026
Plasma Fibrinogen Predicts Response to Immune Checkpoint Inhibitor by Inflammatory Tumor Microenvironment in Esophageal CancerKeiso Ho, Satoru Matsuda, Eisuke Booka, et al.
Annals of Surgical Oncology|January 14, 2026
Optimal Timing of Surgery Following Neoadjuvant Therapy for Surgical and Oncological Outcomes in Advanced Esophageal Squamous Cell Carcinoma: An Exploratory Analysis of JCOG1109Ryosuke Kita, Ken Kato, Ryunosuke Machida, et al.
Annals of Surgical Oncology|August 8, 2020
ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer PatientsSatoru Matsuda, Hiroya Takeuchi, Hirofumi Kawakubo, et al.
Annals of Gastroenterological Surgery|January 16, 2023
Defining conversion therapy for esophageal squamous cell carcinomaSatoru Matsuda, Takahiro Tsushima, Ken Kato, et al.
Pageof 49